Industry Analysis Reports | Health Care | Medical Devices

Wednesday, 30 September 2020

Global Trends On Non-Alcoholic Steatohepatitis Biomarkers Market (2018-2020) | Trends | report| News and Forecast

Non-Alcoholic Steatohepatitis Biomarkers Market Industry Landscape

The arrival of the novel Coronavirus pandemic is anticipated to create significant roadblocks for companies working in the current non-alcoholic steatohepatitis (NASH) biomarkers market. But at the same time and according to the latest study conducted by Market Research Future, global non-alcoholic steatohepatitis (NASH) biomarkers market is expected to grow at a staggering CAGR of ~20.92% in the course of period 2016–2024. Also, during this course of growth, the market would be achieving revenue of USD 1,960.4 million with ongoing rising healthcare industry activities and importance.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7984

(***MRFR FREE SAMPLE COPY of the Report Gives a Brief Introduction to the Research Report, Industry Insight, Size and Forecast, Drivers, Challenges, Trends, Including COVID19 Impact Analysis, Full TOC (123 pages with 143 data tables and 34 figures of the report), an Analysis of the Industry Key Players and comprising Key Regions.***)

Non-Alcoholic Steatohepatitis Biomarkers Market Growth & Attributes

Non-alcoholic steatohepatitis is a superior stage of non-alcoholic fatty liver disease (NAFLD), which arises mainly during the excess fat accumulation and causes inflammation and damage, leading to liver scarring. A biomarker is the most useful diagnostic tool for measuring the biological state and is termed as a pointer for measuring normal biological processes and pathogenic processes in the body. Biomarker tools accessible for diagnosing NASH conditions are known as non-invasive tools, and few of them are biomarker panels, serum biomarkers, imaging biomarkers, fibrosis biomarkers, and others. The rise in research & development is likely to offer promising biomarkers for the accurate diagnosis of NASH condition in the future.

The global non-alcoholic steatohepatitis biomarkers market is driven by the surge in prevalence of NAFLD & NASH disease, hefty unmet needs in terms of disease epidemiology and available diagnostic and therapeutic tools, mount in demand for non-invasive diagnostic methods, rise in geriatric population, upward incidences of obesity and type 2 diabetes, awareness about diagnostic tools as well as the inclination of government focus toward proposing better healthcare services. These factors are probable to propel the non-alcoholic steatohepatitis (NASH) biomarkers market across the globe at a higher note in the precise timeframe.

The adoption of conventional techniques to address non-alcoholic steatohepatitis biomarkers such as biopsy is steadily declining owing to limitations such as sampling bias, and complications such as mortality, bleeding, pain, and poor acceptability. The demand for non-invasive techniques to treat NAFLD has observed steady growth over the past decade. Non-invasive techniques that have gained noteworthy popularity to combat NAFLD include NAFLD-based fibrosis, NASH, and steatosis, and more. In fact, the surge in demand for these non-invasive techniques is probable to boost the demand for NASH biomarkers during the assessment period.

At the same time, in recent times, many significant players operating in the global NASH biomarkers are progressively investigating the algorithms that consist of non-imaging and imaging biomarkers to identify fibrosis and minimize biopsies in clinical settings. Technological advancements, research, and development activities coupled with an elevated prevalence of NAFLD are some of the foremost factors that are likely to drive the expansion of the non-alcoholic steatohepatitis (NASH) biomarkers market during the assessment period.

Non-Alcoholic Steatohepatitis Biomarkers Market Segment Review

The global non-alcoholic steatohepatitis biomarkers market has been studied under the segments of type and end-user.

Depending on the type segment, the market included hepatic fibrosis biomarkers, serum biomarkers, oxidative stress biomarkers, apoptosis biomarkers, and others.

Depending on the end-user segment, the market included research institutes and academics, pharmaceutical companies and CROs, diagnostic centers, hospitals & clinics, and others. The pharmaceutical companies and CROs segment grabbed a market value of USD 226.7 million in 2018.

Non-Alcoholic Steatohepatitis Biomarkers Market Regional Aspect

Regionally, the global non-alcoholic steatohepatitis (NASH) biomarkers market has been studied among the regions of Europe, North America, Latin America, Asia Pacific, and Middle East & Africa. North America led the global non-alcoholic steatohepatitis (NASH) biomarkers market in 2018 and now has acquired a significant share of the global non-alcoholic steatohepatitis (NASH) biomarkers market. The growth has been attributed to the hefty patient pool suffering from NASH and NAFLD indication, along with escalating liver diseases. In fact, a considerable rise in prevalence of obesity and Type 2 diabetes, a rise in demand for a non-invasive diagnostic tool such as biomarkers as well as the adoption of emerging and innovative biomarkers are few major attributable factors for the NASH biomarkers market growth in the forecast period.

Non-Alcoholic Steatohepatitis Biomarkers Market Vendor Landscape

The prime vendors operating in the global non-alcoholic steatohepatitis (NASH) biomarkers market include Echosens (France), Cisbio (France), GENFIT (France), Enterome (France), NGM Biopharmaceuticals (US), Laboratory Corporation of America Holdings (US), Pacific Biomarkers (US), One Way Liver, SL (Spain), Perspectrum Diagnostics Ltd (UK), Regulus Therapeutics, Inc. (US), Quest Diagnostics, Shenzhen New Industries Biomedical Engineering Co., Ltd (China), Siemens Healthineers (Germany), and Xeptagen SpA (Italy).

April 2020: Sequoia-backed in-vitro diagnosis focused biomedicine company Shenzhen New Industries Biomedical Engineering Co., Ltd (also known as Snibe) has kicked off its IPO subscription exercise. It targeted to raise 1.29 billion yuan ($183 million) on the ChiNext board of the Shenzhen Stock Exchange.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Diagnostic Electrocardiograph (ECG) market-Regional trends, Analysis and Growth

Market Forecast

The Global Diagnostic Electrocardiograph (ECG) market 2020 is touted to secure a value of USD 10.48 billion by 2025 and is projected to mature at a growth of 6.72% over the review period.

Market Synopsis

The growth of the global market for diagnostic electrocardiographs (ECG) will lead to the growing prevalence of cardiovascular diseases, rising geriatric population and evolving healthcare infrastructure. In addition, the rising incidence rate of lifestyle diseases, technological advancements in wireless tracking & wearable devices, and industry players' growing R&D spending on developing novel ECG devices are also expected to boost industry growth during the forecast period.

The lack of trained practitioners, instability in market penetration and economic conditions and inconsistent reimbursement policies, however are expected to restrain the growth of the global diagnostic electrocardiograph (ECG) market.

Segmental Analysis

The global diagnostic ECG market has been segmented based on the product type, lead type, and end user.

The global diagnostic electrocardiograph (ECG) market, depending on the product type, has been segmented into ECG resting devices, ECG stress devices, implantable loop recorders, handheld cardiac telemetry devices, event monitors, Holter monitors, and smart ECG monitors. Due to its high use in hospitals around the world, the Resting ECG devices segment held the largest market share in 2018.

The market was segmented by lead form into 12-lead ECG devices, 5-lead ECG devices, 3-lead ECG devices, 6-lead ECG devices, and one-lead ECG devices. Due to their growing usage in a variety of cardiac diagnostic tests, the 3-lead ECG devices segment is touted to rise at the fastest CAGR during the forecast period.

The end-user-based industry was segmented into hospitals & clinics, outpatient surgical centres, and others. The section of the outpatient surgical center is expected to display the fastest growth during the forecast period because of its growing popularity in developing countries.

Regional Overview

Geographically, the global diagnostic ECG market is studied under five different regions namely, North America, Asia Pacific, Latin America, Europe, and MEA.

Due to the increasing need for minimally invasive procedures, North America has represented the largest share of the diagnostic ECG market in the past few years. The significant proportion of this geographic segment can be attributed to the growing prevalence of CVD, the emergence of advanced healthcare services , high disposable income , high demand for medical devices and advances in technology.

It is anticipated that Asia Pacific will report the highest growth over the review period. Factors such as a growing geriatric population, a growing incidence of chronic diseases and rising government spending on health care are expected to drive the te market over the review period. In addition , the large population base, healthcare reforms for infrastructural development, and increasing demand for advanced technology to expand healthcare facilities in emerging economies are also projected to fuel regional market growth. In addition , rising expendable income, advancing healthcare infrastructure as a result of growing technological integration and less stringent regulations also drive demand for ECG diagnostic devices in the Asia Pacific region.

Competitive Dashboard

Some of the major players in the Global Diagnostic Electrocardiograph (ECG) Market are Koninklijke Philips N.V. (Netherlands), Hillrom Services, Inc. (US), Spacelabs Healthcare (US), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Schiller (Switzerland), General Electric Company (US), ACS Diagnostics (US), Fukuda Denshi (Japan), BPL Medical Technologies (India), BTL (US), Edan Instruments, Inc. (China), Cardioline SpA (Italy), Norav Medical (US), Innomed Medical Inc. (Hungary), and VectraCor, Inc. (US). The global market for diagnostic electrocardiographs (ECG) is highly competitive and the major players have used various approaches such as new product releases, extensions, alliances, joint ventures, collaborations, acquisitions and others to expand their footprints in this market.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Tuesday, 29 September 2020

NEWS: Dental Sterilization Market Updates, Size, Share, Report, 2020, Demand

Dental Sterilization Market Research Report by Product (Sterilization Equipment, Surface Disinfectant, Instrument Disinfectant, Washer Disinfector, Lubricant, Cleaning Solutions), End-User (Hospitals, Dental Laboratories) - Global Forecast To 2023

Dental sterilization is a highly crucial part of maintaining the tools and techniques related to dentistry. As per the latest published report by Market Research Future (MRFR), the global dental sterilization market is expected to grow at a CAGR of 6.90% during the forecast period of 2017 to 2023. The market valuation is expected to jump from USD 1.11 billion back in 2017 to USD 1.5 billion by the end of the forecast period.

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6659

A key driver influencing the demand for dental sterilization is the widespread prevalence of dental related diseases or disorders. Dental caries, one of the most common tooth-related issues, is one of the primary reasons behind the loos of tooth and remains a significant concern across developed economies in the world. Consumption of fast food and sugar-rich food items are acting as the main culprits behind incidences of tooth decay and is likely to continue in the coming years as well, thereby driving the growth of the market over the forecast period.

One of the biggest results out of the growing prevalence of dental diseases have been the rising number of dental care facilities. The growth factor associated with the dentistry field is likely to continue in the near future. This, in turn, helps drive the dental sterilization market towards a period of growth.

Market Segmentation

The global dental sterilization market comprises of the following segments: products and end-users.

By product type, the market includes consumables, instruments, and accessories. Among these, the instruments segment is most likely to maintain its dominance over others in terms of market share contribution during the forecast period.

By end-user, the market divides into dental laboratories and hospitals. The hospitals segment is most likely to remain the largest contributor of the two during the forecast period.

Regional Analysis

The geographical segmentation of the global dental sterilization market covers the following regions, Europe, Asia Pacific, North America, and the Rest of the World.

North America leads the chart with the highest market share percentage in the global dental sterilization market. This is primarily due to the widespread prevalence of dental-based diseases in the region and ease of availability concerning the use of advanced dental sterilization equipment. Dental caries is one of the most common requirement in dental hygiene, especially in the US, and affects close to 90% of the school-going children. All these factors are poised to make the North American market maintain its topmost standings over the forecast period.

The Asia Pacific region is considered to be an emerging region in the global landscape, however, it plays a major role in the overall development of the market. Herein, fast-paced urbanization in developing countries like India and China has incepted the adoption of Western-like diet system. This has posed to be an increasing problem for the dental health of consumers residing in the Asia Pacific region. Alongside this, the growing number of dental care centers and clinics across these countries is increasingly likely to drive the demand for the global dental sterilization market in the Asia Pacific region during the forecast period.

Competitive Analysis

The global dental sterilization market comprises of a number of key players, including Matachana Group, Planmeca Group, Danaher, A-Dec, Hu-Friedy, Scican, Tuttnaue, W&H, BMT Medical Technology, Getinge, Midmark, Dentsply Sirona, Nakanishi, Crosstex, and Premier Dental.

March 12^th, 2019, Planmeca became the first-ever dental manufacturer to offer a comprehensive suite of IoT solutions for large clinics as well as clinic chains. The unique device of Planmeca makes it easy to access different sets of data and analyze the same.

March 12^th, 2019, Planmeca and Navigate Surgical Technologies, aka NST, a recognized provider of real-time surgical navigation services, announced their collaboration in order to launch innovative solutions for dental implant surgeries. The partnership is promises to offer dental implant surgeons to deliver enhanced and clinical patient outcomes. The tech offers more precise and accurate implant placement.

TABLE OF CONTENTS

1 Executive Summary

2 Market Introduction

2.1 Market Definition

2.2 Scope Of The Study

2.3 List Of Assumptions

2.4 Markets Structure

3 Market Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics Of Global Dental Sterilization Market

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

4.5 Challenges

4.6 Trends/Technology

5 Market Factor Analysis Of Global Dental Sterilization Market

5.1 Supply Chain Analysis

5.2 Porter’s Five Forces Analysis

Global Dental Sterilization Market, By Product

6.1 Introduction

6.2 Instruments

6.3 Consumables

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Creatinine Test Market Share- Research Report, Analysis by Top Companies, Key Trends and Forecast

Market Highlights

Creatinine test is a part of renal function tests that determine the normal functioning of kidney. It is usually recommended by the healthcare provider for diagnosis of kidney diseases, kidney failure, and other diseases associated with the kidney. Analyzer, creatinine tests strips, cartridge, and other accessories are most widely used to determine creatinine levels signaling the presence of kidney disease.

Prevalence of chronic kidney disease is on the rise across the globe, especially, in the developing countries. The market is driven by the increasing prevalence of diabetes, renal dysfunction, and other kidney problems. Furthermore, increasing research and development activities, and technological advancements to identify the causes and risk factors for renal diseases are fuelling the global market growth. The growth of the market is restricted by the accuracy and reliability of tests.

The global creatinine test market is expected to grow at a CAGR of 4.2% during the forecast period.

Some of the key players in the global market are Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia), Bayer (U.S.), Beckman Coulter (U.S.), Laboratory Corporation of America Holdings (U.S.), Genoptix (U.S.), Healthscope (Australia), Labco (Kuwait), Charles River (U.S.), OPKO Health, Inc. (U.S.), Abbott (U.S.), and others.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Creatinine test market research report–Global forecast till 2023.”

Major Players in Creatinine test Market:

Regional Analysis

The creatinine test market share is increasing in the Americas owing to growing emphasis on healthy lifestyle, and prevention of chronic kidney diseases. Additionally, increasing demand for technologically advanced diagnostic devices and the presence of major market players influence the growth of the market. According to the Centre for Disease Control and Prevention, in 2014, nearly 118,000 people in the U.S. started treatment for End-Stage Renal Disease (ESRD).

In Europe, extensive research and development activities on the medical devices, and extensive use of point-care-testing devices drive the market growth. As per the article published in Clinical Kidney Journal, the incidence of end-stage renal disease (ESRD) varies substantially between the countries in Europe. Furthermore, rising healthcare expenditure also impact the market growth. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current healthcare expenditure of EUR 237 billion, followed by the U.K (EUR 223 billion).

Owing to the increasing prevalence of diabetes, chronic kidney disease, and obesity, and availability of diagnostic services drives the growth of the Asia Pacific region. India and China are the top two countries with high prevalence of diabetes, which is expected to grow in the coming future.

In the Middle East & Africa, the increasing demand for specialty diagnostic services and developing healthcare system drive the growth of the market. In Africa, the demand for diagnosis and treatment of chronic diseases is increasing, which is fuelling the market growth.

Segmentation

The global creatinine tests market is segmented on the basis of type, indication, devices, and end user.

On the basis of the type, the market is segmented into urine test, blood test, and others.

On the basis of the devices & accessories, the market is segmented into clinical analyzer including bench top, and portable/ handheld analyzers, creatinine test strips, cartridge, and others.

On the basis of the indication, the market is segmented into kidney disease, kidney infection, kidney failure, urinary tract obstruction, and others.

On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.

Access Complete Report @ https://www.marketresearchfuture.com/reports/creatinine-test-market-4878

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Global Industry Demand On Body Contouring Devices and Procedures Market

Global Market for Body Contouring Devices and Procedures

Overview

Body contouring is a process of removal of extra fat of skin left after pregnancy or weight loss. Unhealthy lifestyles are leading to an increase in problems like obesity. With the increase in patient count, there is a significant increase in the body contouring procedures market. The global market for contouring devices and procedures is projected to show nearly 07% annual growth rate on global levels. With the advancement in technology, the techniques now have better safety features, efficiency and success rates, which are proving to be the positives for this market and are helping it grow.

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1343

Unlike earlier procedures, now more non-invasive procedures have come to market which can be handled by clinics and spa centres. Obesity is now visible in every age group and every part of the society due to less time for exercise, unhealthy eating and lifestyles. As a result, there is an increasing demand for body contouring techniques. These techniques are also seen as faster and secure escape routes to attain a perfect body, hence making it famous and successful globally.

Apart from these positive factors, strict rules and regulations imposed by authorities are proving one of the hindering agents for the Body Contouring Devices and Procedures Market. Secondly, body contouring procedures are very costly, making it still a faraway story for lower parts of the societies and growing economies. Continuous research & development programs are carried by companies to look for more accessible, efficient and cost-effective measures, which can help in the expansion of global body contouring devices and procedures market.

Market Segments of Body Contouring Devices and Procedures

There are three segments to this market:

Device Types: There are three types of body contouring, namely, non-invasive, minimally invasive and invasive devices.

Procedures Type: Body contouring includes non-invasive skin treatments, liposuction, cellulite treatments and others.

End-user: All the healthcare services like clinics, hospitals and spas are using this technology. Also, the introduction of non-invasive techniques has made it even more popular.

Regional Overview

There are four key regions to this market America, Europe, Asia Pacific and The Middle East & Africa, currently the major markets in that order.

America is currently dominating the market with the presence of major players. High per capita income, unhealthy lifestyle and easy availability of contouring techniques helped the market to grow. Europe is in second place, owing to factors like an abundant investment and research programs are at large in this region. The Asia Pacific is at third place currently but will emerge as the fastest growing market due to its dense population, increase in medical healthcare sector an awareness among the masses. The Middle East & African market will grow at the slowest pace and is expected to hold the same place in the table until the next survey.

Recent Industry News

With the introduction of non-invasive and minimally invasive products, which reduces the surgical dangers, the global market for body contouring devices and procedures has earned a lot of speed and fame. High cost and strict regulations are holding back the market from growing at the desired rate. Companies should be regularly working in innovations and researches fields to eradicate the negatives and gain more share of the market. With a high population, increasing standards and demand for new medical procedures, Asia Pacific will emerge as the fastest-growing market in the projected time.

Read Complete Report with Toc @ https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Post-operative Pain Management Market : 2020 | size| Share | Report and Growth Factors

Post-operative Pain Management Market Analysis

The global post-operative pain management market is predicted to grow at a 5.4% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR) report. Post-operative pain is unpleasant and annoying, which, if not treated correctly and on time, can result in chronic pain, which may last for months. Post-operative pain is a common adverse outcome owing to physical distress, prolonged hospital stays, and the growing incidence of readmissions of patients after surgery. Post-operative pain management helps in minimizing patient discomfort, facilitating early mobilization, functional recovery along with preventing acute pain turning into chronic pain. Besides, it also helps to lessen the possibility of pulmonary, cardiac, and neuropathic pain complications, low cost of care, and cut down the risk of thrombosis.

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1246

Various factors are propelling the post-operative pain management market growth. These factors, as per the new Market Research Future (MRFR) report, include growing incidence of diseases that need surgical treatments, development of novel drugs for quick pain relief, increased R&D activities to develop high-quality post-operative pain management solutions with minimum side effects, increasing prevalence of various chronic diseases such as cardiovascular diseases, renal diseases, cancer, and others, and increase in geriatric population. Additional factors pushing market growth include the increasing number of cancer patients and burgeoning demand for pain control devices and drugs.

On the flip side, poor primary health care services, especially in underdeveloped regions and complications related to overdose of pain management drugs, are factors that may impede the post-operative pain management market growth over the forecast period.

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the Post Operative Pain Management Market Growth on the basis of target area, application, product, and pain type.

Based on pain type, the post-operative pain management market is segmented into severe pain, moderate pain, and acute pain.

Based on the product, the post-operative pain management market is segmented into opioids, COX-2 inhibitors, antiepileptic drugs, non-steroidal anti-inflammatory drugs, and other analgesics.

Based on the application, the post-operative pain management market is segmented into migraine, musculoskeletal pain, neuropathic pain, arthritic pain, cancer pain, and others. Of these, the cancer pain segment will have the largest share in the market over the forecast period.

Based on target area, the global post-operative pain management market is segmented into arms, hand, legs, back, and others.

Regional Analysis

By region, the post-operative pain management market report covers the latest trends and growth opportunities across the Asia Pacific (APAC), the Americas, Europe, and the Middle East and Africa. Of these, the Americas will dominate the market over the forecast period. This is chiefly on account of the presence of well-developed healthcare infrastructure in the region and the huge patient pool undergoing surgical procedures.

The post-operative pain management market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly on account of the increasing R&D activities for the launch of new drugs with minimal side-effects.

The post-operative pain management market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is chiefly on account of the growing incidence of chronic diseases that needs surgical treatment coupled with an increase in the geriatric population.

The global post-operative pain management market in the MEA is predicted to have steady growth over the forecast period. This is chiefly on account of poor primary health care services, especially in the region’s underdeveloped areas and lack of awareness.

Key Players

Prominent players profiled in the post-operative pain management market report include Valeant Pharmaceuticals International Inc. (Canada), Baxter International Inc. (the US), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline Plc. (the UK), Forest Laboratories Inc. (the US), Endo Pharmaceuticals Plc. (the US), Purdue Pharma (the US), Johnson & Johnson (the US), Pfizer (the US), Eli Lilly (the US), and Teva Pharmaceutical Industries Ltd. (Israel). Key players have incorporated several strategies to create a niche in the market, such as research and development activities, joint ventures, expansions, product launches, and more.

Industry News

August 2019: Dr. Reddy’s Laboratories has recently launched generic anti-epileptic Vigabatrin powder in the US market for oral solution.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Neurovascular Devices Market will Reflecting a CAGR of 8.8% by 2023

Neurovascular Devices Market Highlights

Neurovascular devices encompass a range of devices which are used for neurovascular management. The rise of neurovascular devices such as brain aneurysms, carotid artery disease, and others are likely to warrant advanced devices which can prevent the possibility of strokes and other diseases. The global neurovascular devices market report by Market Research Future (MRFR) comprises a comprehensive analysis of the current state and future predictions for the period of 2018 to 2023 (forecast period).

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544

Neurovascular Devices Market Scope

The global neurovascular devices market is expected to grow at a CAGR of 8.8% during forecast period. It is driven by the rise of neurovascular diseases and development of minimally invasive procedures. According to the Brain Aneurysm Foundation, cerebral aneurysms are accountable for close to a million deaths annually. Progress in neurovascular management and innovations in microsurgical devices and treatments can drive market growth in a positive direction.

Investments by government organizations for management of neurological conditions can bode well for the market. This is exemplified by the use of funds amounting to USD 6.6 billion by the NHS in the U.K. Clinical trials being conducted for new methods and procedures can encourage market growth. Endovascular treatments are gaining traction with many patients opting it as a method for acute ischemic stroke.

However, high procedural costs and lack of skilled physicians can dampen the market growth prospects.

Neurovascular Devices Market Segmentation

The global neurovascular devices market is segmented by product, therapeutic application, and end-user.

On the basis of the product, the market is segmented into, aneurysm coiling & embolization devices, neurothrombectomy devices, cerebral balloon angioplasty and stenting systems, and support device. Aneurysm coiling & embolization devices are sub-segmented into liquid embolic, embolic coils, and flow diversion devices. Embolic coils, a part of aneurysm coiling & embolization devices segment, are further segmented into detachable coils and pushable coils. Similarly, neurothrombectomy devices segment is sub-segmented into suction and aspiration devices and retrieval systems. The support device segment is sub-segmented into microcatheters and microguidewires. The cerebral balloon angioplasty and stenting systems segment is sub-segmented into carotid artery stents and embolic protection systems. Embolic protection systems are further divided into distal filter devices and balloon occlusion devices.

By therapeutic application, the global neurovascular devices market is categorized into hemorrhagic stroke and ischemic strokes.

By end-users, the market is segmented into hospitals & clinics and ambulatory surgical units.

Neurovascular Devices Market Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa are regions considered for measuring the value and volume of the global neurovascular devices market.

The Americas are touted to dominate the global neurovascular devices market owing to high prevalence of neurovascular diseases. According to a study by the Methodist DeBakey Cardiovascular Journal in 2014, close to 1 million strokes occur annually due to intracranial atherosclerotic disease. The large healthcare expenditure of nations in the region and presence of major players can further regional market growth.

APAC is predicted to exhibit a stellar growth rate during the forecast period owing to the growth of economies of China and India. Demand for minimally invasive surgeries by the geriatric populace can fuel the demand in the global neurovascular devices market.

Neurovascular Devices Market Competitive Outlook

Evasc, OxfordEndovascular, Gynesonics, Delaware Corporation, TERUMO CORPORATION, Merit Medical Systems, Inc., Secant Group, LLC, Rapid Medical, Neuravi, Medikit co., ltd., Stryker, Abbott, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Penumbra, Inc., Johnson & Johnson Services, Inc., Blockade Medical, LLC., and Sensome are major players of the global neurovascular devices market. Product launches, acquisitions, and distribution agreements are strategies being implemented by players to sustain their position in the market. In 2020, Arterio Medical submitted the results of the clinical trial of Endura Embolization System in bifurcation systems. The results demonstrated the low relapse of coils and provide immediate cerebral aneurysm occlusion.

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Wednesday, 30 September 2020

Global Trends On Non-Alcoholic Steatohepatitis Biomarkers Market (2018-2020) | Trends | report| News and Forecast

Diagnostic Electrocardiograph (ECG) market-Regional trends, Analysis and Growth

Tuesday, 29 September 2020

NEWS: Dental Sterilization Market Updates, Size, Share, Report, 2020, Demand

Creatinine Test Market Share- Research Report, Analysis by Top Companies, Key Trends and Forecast

Market Highlights

Global Industry Demand On Body Contouring Devices and Procedures Market

Post-operative Pain Management Market : 2020 | size| Share | Report and Growth Factors

Neurovascular Devices Market will Reflecting a CAGR of 8.8% by 2023

Blog Archive

Total Pageviews